A Study of MRG002 in the Treatment of Patients With HER2-positive Advanced Solid Tumors
Clinical trial NCT04941339 · UNKNOWN
Trial details
- NCT number
- NCT04941339
- Sponsor
- Shanghai Miracogen Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-21
- Primary completion
- 2022-10-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.